Jerry Louis - Feb 15, 2024 Form 4 Insider Report for ContextLogic Inc. (WISH)

Role
Chief Technology Officer
Signature
/s/ Marianne Lewis, Attorney-in-Fact
Stock symbol
WISH
Transactions as of
Feb 15, 2024
Transactions value $
-$43,605
Form type
4
Date filed
2/20/2024, 06:26 PM
Previous filing
Nov 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WISH Class A Common Stock Options Exercise $0 +15.6K +43.97% $0.00 50.9K Feb 15, 2024 Direct F1, F2
transaction WISH Class A Common Stock Tax liability -$43.6K -6.38K -12.52% $6.84 44.5K Feb 15, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WISH Restricted Stock Unit Options Exercise $0 -1.37K -12.5% $0.00 9.55K Feb 15, 2024 Class A Common Stock 1.37K $0.00 Direct F4, F5
transaction WISH Restricted Stock Unit Options Exercise $0 -496 -50% $0.00 496 Feb 15, 2024 Class A Common Stock 496 $0.00 Direct F4, F6
transaction WISH Restricted Stock Unit Options Exercise $0 -9.52K -12.5% $0.00 66.7K Feb 15, 2024 Class A Common Stock 9.52K $0.00 Direct F4, F7
transaction WISH Restricted Stock Unit Options Exercise $0 -4.17K -33.33% $0.00 8.33K Feb 15, 2024 Class A Common Stock 4.17K $0.00 Direct F4, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person received restricted stock units ("RSUs") which represent a contingent right to receive one share of Issuer's Class A Common Stock for each RSU. This reported transaction represents the settlement of RSUs vested as of February 15, 2024.
F2 Includes 166 shares acquired under ContextLogic's employee stock purchase plan on November 20, 2023.
F3 Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the settlement of RSUs.
F4 This reported transaction represents the settlement of RSUs vested as of February 15, 2024.
F5 Each RSU represents a contingent right to receive one share of Class A Common Stock. Subject to the Reporting Person's continued service, 25% of the RSUs vested on March 9, 2021, and an additional 1/36 of the remaining RSUs vest monthly thereafter for a period of 3 years.
F6 Each RSU represents a contingent right to receive one share of Issuer's Class A Common Stock. Subject to the Reporting Person's continuous service, 12.5% of the RSUs will vest on a quarterly basis beginning on February 15, 2022 (with all quarterly vesting events occurring on a "Company Vesting Date" of February 15, May 15, August 15, or November 15). Vested RSUs will settle on or following the vesting date, but in any event within 60 days following the vesting date (unless the Reporting Person and the Company have agreed in writing to a later settlement date pursuant to procedures the Company may prescribe at its discretion).
F7 Subject to the Reporting Person's continuous service, 10% of the RSUs will vest on a quarterly basis beginning on May 15, 2023 (with all quarterly vesting events occurring on a "Company Vesting Date" of February 15, May 15, August 15, or November 15). Vested RSUs will settle on or following the vesting date, but in any event within 60 days following the vesting date (unless the Reporting Person and the Company have agreed in writing to a later settlement date pursuant to procedures the Company may prescribe at its discretion).
F8 Each RSU represents a contingent right to receive one share of Issuer's Class A Common Stock. Subject to the Reporting Person's continuous service, 12.5% of the RSUs will vest on a quarterly basis beginning on November 15, 2022 (with all quarterly vesting events occurring on a "Company Vesting Date" of February 15, May 15, August 15, or November 15). Vested RSUs will settle on or following the vesting date, but in any event within 60 days following the vesting date (unless the Reporting Person and the Company have agreed in writing to a later settlement date pursuant to procedures the Company may prescribe at its discretion).